Dice CEO: Energy, T...
Health Care: Health Services
Antares Pharma Inc. (AIS: AMEX)
$2.76 0.04 | 1.47%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 19.36M | 9.85M | 13.56M | 13.10M |
| Receivables | 2.54M | 1.25M | 1.54M | 1.33M |
| Inventories | 891.76K | 272.46K | 329.55K | 182.04K |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 36.27M | 12.48M | 16.55M | 14.91M |
| Property, Plant & Equipment, Gross | 2.48M | 2.26M | 2.17M | 5.25M |
| Accumulated Depreciation & Depletion | 1.89M | 1.93M | 1.85M | 3.46M |
| Property, Plant & Equipment, Net | 591.67K | 327.54K | 317.31K | 1.79M |
| Intangibles | 952.39K | 803.43K | 742.40K | 644.86K |
| Other Non-Current Assets | 3.06M | 439.48K | 439.09K | 1.48M |
| Total Non-Current Assets | 5.70M | 2.67M | 2.59M | 5.00M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 41.96M | 15.14M | 19.14M | 19.91M |
| Accounts Payable | 2.14M | 1.77M | 1.88M | 2.10M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 10.01M | 6.67M | 8.24M | 7.37M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 2.24M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 810.39K | 1.84M | 2.05M | 3.06M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 810.39K | 1.84M | 2.05M | 5.30M |
| Total Liabilities | 10.82M | 8.51M | 10.29M | 12.67M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 31.14M | 6.63M | 8.85M | 7.24M |
| Common Par | 1.04M | 841.58K | 818.00K | 680.50K |
| Additional Paid In Capital | 172.07M | 143.32M | 139.61M | 127.93M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -141.36M | -136.97M | -130.88M | -120.59M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -595.32K | -559.84K | -699.33K | -771.59K |
| Total Capitalization | 31.14M | 6.63M | 8.85M | 9.48M |
| Total Equity | 31.14M | 6.63M | 8.85M | 7.24M |
| Total Liabilities & Stock Equity | 41.96M | 15.14M | 19.14M | 19.91M |
| Total Common Shares Outstanding | 103.55M | 84.16M | 81.80M | 68.05M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 96.99M | 83.17M | 73.49M | 67.23M |
| Diluted Weighted Shares Outstanding | 96.99M | 83.17M | 73.49M | 67.23M |
| Number of Employees | 29 | 21 | 19 | 24 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with AIS
- Portfolio NameUser Type
- Contributor5 Stocks Under-$10 Setting ...
- UserSMITTY
- Contributor8 Health Care Stocks With R...
- ContributorBreakout Stocks Of The Week...
- UserCurrent
- Userparvardigar
- Userhpats Portfolio 1
- Contributor11 Penny Stocks to Sell Now
- Userphospho
- UserTraderO4000 Portfolio 1
Latest AIS Headlines from TheStreet
- Antares Stock Hits New 52-Week High (AIS) 03.20.12 | 11:03 am
- Antares Pharma Inc. Stock Upgraded (AIS) 03.14.12 | 05:03 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Antares Stock Gaps Down On Today's Open (AIS) 12.15.11 | 09:12 am
- BioSante Pharma Readying Release of 'Female Viagra' Study Results 12.14.11 | 12:12 pm
- 5 Stocks Under $10 With Big Upside Potential 11.18.11 | 06:11 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- 4 Stocks Setting Up to Break Out 06.10.11 | 03:06 pm
- 11 Penny Stocks to Sell Now 07.20.10 | 11:07 am
- Hot Penny Stocks to Buy 06.14.10 | 11:06 am
Press Releases for AIS
- Antares Pharma To Present At The Jefferies Global Healthcare Conference - Business Wire 05.31.12 | 07:05 am
- Antares Pharma Reports First Quarter 2012 Financial And Operating Results - Business Wire 05.08.12 | 07:05 am
- Antares Pharma Announces Epinephrine Auto-Injector Settlement Agreement Between Teva And Pfizer - Business Wire 04.26.12 | 09:04 am
- Antares Pharma To Present At The 11th Annual Needham Healthcare Conference - Business Wire 03.28.12 | 07:03 am
- Antares Pharma Reports Fourth Quarter And Full Year 2011 Financial And Operating Results - Business Wire 03.12.12 | 07:03 am
- Antares Pharma To Host Fourth Quarter And Full Year 2011 Earnings Call - Business Wire 03.05.12 | 07:03 am
- Antares Pharma To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 07:02 am
- Antares Pharma Appoints John J. Howarth Vice President Of Corporate Affairs - Business Wire 02.27.12 | 09:02 am
- Antares Pharma Enters Licensing Agreement With Daewoong Pharmaceuticals Co. Ltd. For Oxybutynin Gel 3% In South Korea - Business Wire 01.17.12 | 08:01 am
- Antares Pharma Enters Licensing Agreement With Pfizer Consumer Healthcare - Business Wire 12.20.11 | 09:12 am
Partner Headlines for AIS
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 05.14.12 | 09:05 am
- BioDelivery's Spike May Be A Short-Lived Downer - Seeking Alpha 04.04.12 | 08:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- A Bio-Pharma Watch List For This Week: 4 Buys, 1 Sell - Seeking Alpha 02.22.12 | 09:02 am
- SIGA Could Be Ready For A Large Short-Term Pop - Seeking Alpha 01.15.12 | 09:01 am
- Antares Pharma's New Blockbuster Drug Has Potential To Generate Long-Term Revenue - Seeking Alpha 12.28.11 | 06:12 am
- Watson-Amgen to Develop Biosimilars - Analyst Blog - Zacks 12.20.11 | 10:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
